NCT01017146 - A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301 | Biotech Hunter

Enrollment

744

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions

Acne Vulgaris

Interventions

DRUG

Tazarotene foam

Tazarotene foam once a day application to the face

DRUG

Vehicle Foam

Vehicle Foam once a day application to the face

Trial Locations (22)

11790

DermResearch Center of New York, Inc., Stony Brook

19067

Yardley Dermatology Associates, Yardley

27157

Wake Forest University Health Sciences, Winston-Salem

27262

Dermatology Consulting Services, High Point

33140

Cosmetic Medicine & Treatment Research Insttitute, Inc., Miami Beach

37203

Dermatology Research Associates, Inc., Nashville

37922

The Skin Wellness Center, PC, Knoxville

44118

Haber Dermatology & Cosmetic Surgery, Inc., South Euclid

45220

The Dermatology Research of Cincinnati, Cincinnati

Group Health Associates, Cincinnatti

46260

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

53209

Aurora Advanced Healthcare, Inc. Clinical Research Center, Milwaukee

55432

Minnesota Clinical Study Center, Fridley

75230

Dermatology Treatment & Research Center, Dallas

77845

J & S Studies, Inc., College Station

78759

DermResearch, Inc., Austin

80209

Cherry Creek Research, Inc., Denver

87106

Academic Dermatology Associates, Albuquerque

97210

Oregon Dermatology and Research Center, Portland

L4M 6L2

Ultranova Skincare, Barrie

L8N 1V6

Dermatrials Research, Hamilton

NL A1B 3E1

Nexus Clinical Research, St. John's